Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 454.41
-5.59 (-1.22%)
Sep 25, 2026, 12:45 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 31.28 million as of September 24, 2026. Its market cap has decreased by -55.12% in one year.
Market Cap
31.28M
Enterprise Value
31.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
454.41
ChartMarket Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 31.28M, an increase of 192.85%. That is a compound annual growth rate of 12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 31.28M | -9.48% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 73.32M |
| Poolbeg Pharma | 69.09M |
| Ondine Biomedical | 55.85M |
| Sareum Holdings | 42.96M |
| Arecor Therapeutics | 33.41M |
| ImmuPharma | 22.89M |
| IXICO | 16.42M |
| Oxford BioDynamics | 15.46M |